Site Search
Search Results
Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment
Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... using a plan purchased privately such as through the marketplace. Nine percent of those who did not have biomarker testing say it was because of cost or coverage concerns. This is a significant improvement since the last time this question was asked in 2020, when 29% mentioned cost and ...
Survivor Views: One in Ten Impacted by Recent Drug Shortages
Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... they were a good candidate for it, however most (69%) did not discuss it with their doctor. Nine percent did not have biomarker testing due to cost or coverage concerns. Telehealth Four-in-five agree it is important for cancer patients to have access to telehealth services from out of ...